Publications


Commitment to science

Our commitment to science is reflected in our track record of publications. Here are a few recent examples of high impact publications co-authored by AstraZeneca and/or MedImmune scientists.


Early discovery

Published:

Chem. Rev., Article, Published online: 18 November 2016 DOI: 10.1021/acs.chemrev.6b00466

Author(s):


CVMD

Published:

Circulation. 2016;CIRCULATIONAHA.116.022064 DOI: http://dx.doi.org/10.1161/CIRCULATIONAHA.116.022064

Author(s):


CVMD

Published:

Circulation. 2016;CIRCULATIONAHA.116.024014 DOI: http://dx.doi.org/10.1161/CIRCULATIONAHA.116.024014

Author(s):


Oncology

Published:

Science Translational Medicine 26 Oct 2016: Vol. 8, Issue 362, pp. 362ps17 DOI: 10.1126/scitranslmed.aaf9246

Author(s):


Oncology

Published:

Nature Medicine 22, 1303–1313 (2016), published online 24 October 2016 DOI:10.1038/nm.4198

Author(s):


Oncology

Published:

Nature Chemical Biology (2016) Published online 24 October 2016, doi:10.1038/nchembio.2210

Author(s):


Early discovery

Published:

Nature Chemical Biology (2016), published online 17 October 2016 doi:10.1038/nchembio.2203

Author(s):


Early discovery

Published:

Nature Communications 7, Article number: 12962 (2016) doi:10.1038/ncomms12962

Author(s):


Respiratory

Published:

The Lancet, Volume 4, No. 10, p797–806, October 2016 DOI: http://dx.doi.org/10.1016/S2213-2600(16)30227-2

Author(s):


CVMD

Published:

Nature 538, 248–252 (13 October 2016) doi:10.1038/nature19806

Author(s):


Oncology

Published:

Cell Discovery 2, Article number: 16031 (2016) doi:10.1038/celldisc.2016.31

Author(s):


CVMD

Published:

Cell Metabolism (2016) http://dx.doi.org/10.1016/j.cmet.2016.08.020

Author(s):


Oncology

Published:

Cell, Volume 167, Issue 1, p260–274.e22, 22 September 2016 DOI: http://dx.doi.org/10.1016/j.cell.2016.08.041

Author(s):


Oncology

Published:

Nature Reviews Materials 1, Article number: 16069 (2016) doi:10.1038/natrevmats.2016.69

Author(s):


Oncology

Published:

Nature Chemical Biology (2016) Published online 05 September 2016 doi:10.1038/nchembio.2174

Author(s):


Cardiovascular and Metabolic diseases

Published:

Science 19 Aug 2016: Vol. 353, Issue 6301, pp. 827-830 DOI: 10.1126/science.aad6970

Author(s):


Oncology

Published:

Nature Chemical Biology; 15 August 2016, doi: 10.1038/nchembio.2148

Author(s):



Oncology

Published:

Nature 534, 272–276 (09 June 2016) doi:10.1038/nature17963

Author(s):


Oncology

Published:

Published online 01 June 2016; Nature Reviews Clinical Oncology (2016) doi:10.1038/nrclinonc.2016.79

Author(s):


Medicinal chemistry

Published:

Advanced Drug Delivery Reviews; Volume 101, 1 June 2016, Pages 42–61. http://dx.doi.org/10.1016/j.addr.2016.03.013

Author(s):


Oncology

Published:

Published Online May 13, 2016; doi: 10.1158/2159-8290.CD-15-1246

Author(s):


Respiratory

Published:

12 May 2016 N Engl J Med 2016; 374:1811-1821DOI: 10.1056/NEJMoa1505971

Author(s):



Oncology

Published:

Published online 5 May 2016; Nature Medicine 22, 464–471 (2016) doi:10.1038/nm.4089

Author(s):


Oncology

Published:

Published Online April, 2016; Advanced Drug Delivery Reviews http://dx.doi.org/10.1016/j.addr.2016.04.025

Author(s):


Oncology

Published:

Published online 26 April 2016; Nature Reviews Cancer 16, 319–329 (2016) doi:10.1038/nrc.2016.35

Author(s):


Oncology

Published:

Immunity: Volume 44, Issue 3, 15 March 2016, Pages 698–711 DOI: http://dx.doi.org/10.1016/j.immuni.2016.02.025

Author(s):


Oncology

Published:

Science Translational Medicine 24 Feb 2016: Vol. 8, Issue 327, pp. 327ra26 DOI: 10.1126/scitranslmed.aad6352

Author(s):


Oncology

Published:

Science Translational Medicine 10 Feb 2016: Vol. 8, Issue 325, pp. 325ra17 DOI: 10.1126/scitranslmed.aad2355

Author(s):


Neuroscience

Published:

Neuron, Volume 88, Issue 6, 16 December 2015, Pages 1078–1083 http://dx.doi.org/10.1016/j.neuron.2015.10.047

Authors(s):


Cardiovascular and Metabolic diseases

Published:

Cell Research (2016) 26:119–130. doi:10.1038/cr.2015.143; published online 4 December 2015

Authors(s):


Scientific Partnering and Alliances

Published:

Nature Reviews Drug Discovery 14, 833–841 (2015) doi:10.1038/nrd4707 Published online 20 November 2015

Authors(s):


Discovery sciences

Published:

Nature Reviews Drug Discovery 15, 1–2 (2016) doi:10.1038/nrd.2015.19 Published online 20 November 2015

Authors(s):


Oncology

Published:

Molecular Cell, Volume 60, Issue 4, 19 November 2015, Pages 547–560 http://dx.doi.org/10.1016/j.molcel.2015.10.040

Authors(s):


Personalised healthcare and biomarkers

Published:

14-Nov-15

Authors(s):


Oncology

Published:

Nature 526, 361–370 (15 October 2015) doi:10.1038/nature15819 Received 20 May 2015 Accepted 14 August 2015 Published online 14 October 2015

Authors(s):


Oncology

Published:

Nature Reviews Cancer 15, 577–592 (2015) doi:10.1038/nrc4000 Published online 24 September 2015

Authors(s):


Discovery sciences

Published:

Nature Communications 6, Article number: 8327 (2015) Published online 14 September 2015 doi:10.1038/ncomms9327

Authors(s):


Discovery sciences

Published:

Science Advances  14 Aug 2015: Vol. 1, no. 7, e1500315 DOI: 10.1126/sciadv.1500315

Authors(s):


Oncology

Published:

Nature Communications 6, Article number: 7877 (2015) Published online 23 July 2015 doi:10.1038/ncomms8877

Authors(s):


Oncology

Published:

13-Jul-15: Nature Medicine

ASTRAZENECA/MEDIMMUNE AUTHOR:


Oncology

Published:

In press, published online 19 June 2015: 2015 Nature Reviews Drug Discovery 14, 475–486 (2015) doi:10.1038/nrd4609

Author(s):


Oncology

Published:

May 2015: Nat Commun. 2015;6(7096). doi:10.1038/ncomms8096.

Author(s):


Drug safety and metabolism

Published:

Nature Communications 6, Article number: 6715 (2015) Published online 31 March 2015 doi:10.1038/ncomms7715

Authors(s):


Oncology

Published:

14-Jan-15: Nature Communications

ASTRAZENECA/MEDIMMUNE AUTHOR: